Myositis-associated antibodies (MAAs) are a group of autoantibodies frequently identified in patients with IIMs and have also been detected in patients with other connective tissue diseases (CTDs), in which myositis can occur [1, 6]. This evidence concerns the gene MAPKAPK5-AS1 and myositis disease.